Cargando…
Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
AIM: Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). METHODS: In this prospective, cross-sectional study, we have eval...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925017/ https://www.ncbi.nlm.nih.gov/pubmed/33688490 http://dx.doi.org/10.1155/2021/6670065 |
_version_ | 1783659204610883584 |
---|---|
author | Mikolasevic, Ivana Poropat, Goran Filipec Kanizaj, Tajana Skenderevic, Nadija Zelic, Marko Matasin, Marija Vranic, Luka Kresovic, Andrea Hauser, Goran |
author_facet | Mikolasevic, Ivana Poropat, Goran Filipec Kanizaj, Tajana Skenderevic, Nadija Zelic, Marko Matasin, Marija Vranic, Luka Kresovic, Andrea Hauser, Goran |
author_sort | Mikolasevic, Ivana |
collection | PubMed |
description | AIM: Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). METHODS: In this prospective, cross-sectional study, we have evaluated 937 patients with one or more components of the metabolic syndrome who had an esophagogastroduodenoscopy (EGD) due to GERD symptoms. In all patients, a laboratory analysis, an abdominal ultrasound, and FibroScan measurements were done. GERD was defined by EGD. RESULTS: The mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m(2). The prevalence of increased CAP was 82.6% (774/937). Patients with increased CAP were younger, were more obese, had higher prevalence of hypertension, diabetes, and dyslipidemia, and had higher values of aminotransferases. Similar results of higher prevalence in patients with elevated CAP were observed with GERD, hiatal hernia, and insufficient cardia (defined as deficient or absent closure of the gastric inlet in relation to the esophagus). Additionally, patients with elevated CAP had a higher prevalence of GERD grades B and C in comparison to those without elevated CAP. Consequently, patients who did not have elevated CAP had a higher prevalence of GERD grade A. Even though we have found an upward trend in the prevalence of GERD, hiatal hernia, and insufficient cardia, there was no significant difference between subjects with fibrosis (F) 1-2 and F3-4 stage of fibrosis or F1 and F2-4. In a binary logistic regression, a significant positive association with GERD was obtained for CAP. Furthermore, a significant positive association with hiatal hernia was obtained for BMI and CAP. Finally, a significant positive association with hiatal hernia was obtained with CAP in multivariate analysis. CONCLUSION: To the best of our knowledge, our study is the first to reveal a positive association between CAP as a surrogate marker of liver steatosis and GERD after adjustments for other clinical variables. |
format | Online Article Text |
id | pubmed-7925017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-79250172021-03-08 Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements Mikolasevic, Ivana Poropat, Goran Filipec Kanizaj, Tajana Skenderevic, Nadija Zelic, Marko Matasin, Marija Vranic, Luka Kresovic, Andrea Hauser, Goran Can J Gastroenterol Hepatol Research Article AIM: Our aim was to investigate the association among elastographic parameters of liver steatosis and fibrosis, controlled attenuation parameter (CAP) and liver stiffness measurement (LSM), with gastroesophageal reflux disease (GERD). METHODS: In this prospective, cross-sectional study, we have evaluated 937 patients with one or more components of the metabolic syndrome who had an esophagogastroduodenoscopy (EGD) due to GERD symptoms. In all patients, a laboratory analysis, an abdominal ultrasound, and FibroScan measurements were done. GERD was defined by EGD. RESULTS: The mean body mass index (BMI) of the study population was 30.95 ± 5.45 kg/m(2). The prevalence of increased CAP was 82.6% (774/937). Patients with increased CAP were younger, were more obese, had higher prevalence of hypertension, diabetes, and dyslipidemia, and had higher values of aminotransferases. Similar results of higher prevalence in patients with elevated CAP were observed with GERD, hiatal hernia, and insufficient cardia (defined as deficient or absent closure of the gastric inlet in relation to the esophagus). Additionally, patients with elevated CAP had a higher prevalence of GERD grades B and C in comparison to those without elevated CAP. Consequently, patients who did not have elevated CAP had a higher prevalence of GERD grade A. Even though we have found an upward trend in the prevalence of GERD, hiatal hernia, and insufficient cardia, there was no significant difference between subjects with fibrosis (F) 1-2 and F3-4 stage of fibrosis or F1 and F2-4. In a binary logistic regression, a significant positive association with GERD was obtained for CAP. Furthermore, a significant positive association with hiatal hernia was obtained for BMI and CAP. Finally, a significant positive association with hiatal hernia was obtained with CAP in multivariate analysis. CONCLUSION: To the best of our knowledge, our study is the first to reveal a positive association between CAP as a surrogate marker of liver steatosis and GERD after adjustments for other clinical variables. Hindawi 2021-02-23 /pmc/articles/PMC7925017/ /pubmed/33688490 http://dx.doi.org/10.1155/2021/6670065 Text en Copyright © 2021 Ivana Mikolasevic et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mikolasevic, Ivana Poropat, Goran Filipec Kanizaj, Tajana Skenderevic, Nadija Zelic, Marko Matasin, Marija Vranic, Luka Kresovic, Andrea Hauser, Goran Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements |
title | Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements |
title_full | Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements |
title_fullStr | Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements |
title_full_unstemmed | Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements |
title_short | Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements |
title_sort | association between gastroesophageal reflux disease and elastographic parameters of liver steatosis and fibrosis: controlled attenuation parameter and liver stiffness measurements |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925017/ https://www.ncbi.nlm.nih.gov/pubmed/33688490 http://dx.doi.org/10.1155/2021/6670065 |
work_keys_str_mv | AT mikolasevicivana associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT poropatgoran associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT filipeckanizajtajana associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT skenderevicnadija associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT zelicmarko associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT matasinmarija associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT vranicluka associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT kresovicandrea associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements AT hausergoran associationbetweengastroesophagealrefluxdiseaseandelastographicparametersofliversteatosisandfibrosiscontrolledattenuationparameterandliverstiffnessmeasurements |